Cargando…

Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa

BACKGROUND: Tuberculosis remains the leading cause of death in South Africa. A number of potential new TB vaccine candidates have been identified and are currently in clinical trials. One such candidate is MVA85A. This study aimed to estimate the cost-effectiveness of adding the MVA85A vaccine as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Channing, Liezl, Sinanovic, Edina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169661/ https://www.ncbi.nlm.nih.gov/pubmed/25242892 http://dx.doi.org/10.1186/1478-7547-12-20

Ejemplares similares

Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa
por: Sinanovic, Edina, et al.
Publicado: (2006)

Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa
por: Cox, Helen, et al.
Publicado: (2015)

A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa
por: Duncan, Kristal, et al.
Publicado: (2019)

Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis
por: Foster, Nicola, et al.
Publicado: (2021)

The cost and utilisation patterns of a pilot sign language interpreter service for primary health care services in South Africa
por: Zulu, Tryphine, et al.
Publicado: (2017)

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
por: Vassall, Anna, et al.
Publicado: (2017)

Association between Health-Related Quality of Life and Medication Adherence in Pulmonary Tuberculosis in South Africa
por: Kastien-Hilka, Tanja, et al.
Publicado: (2017)

The costs and cost effectiveness of providing first-trimester, medical and surgical safe abortion services in KwaZulu-Natal Province, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2017)

The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2018)

How to Evaluate Health-Related Quality of Life and Its Association with Medication Adherence in Pulmonary Tuberculosis – Designing a Prospective Observational Study in South Africa
por: Kastien-Hilka, Tanja, et al.
Publicado: (2016)

Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis– a systematic review of global literature with focus on South Africa
por: Kastien-Hilka, Tanja, et al.
Publicado: (2016)

Potential Cost-Effectiveness of a New Infant Tuberculosis Vaccine in South Africa - Implications for Clinical Trials: A Decision Analysis
por: Ditkowsky, Jared B., et al.
Publicado: (2014)

Health-related quality of life in South African patients with pulmonary tuberculosis
por: Kastien-Hilka, Tanja, et al.
Publicado: (2017)

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
por: Schnippel, Kathryn, et al.
Publicado: (2016)

Tuberculosis Prevention in South Africa
por: Knight, Gwenan M., et al.
Publicado: (2015)

The Participation of Children with Intellectual Disabilities: Including the Voices of Children and Their Caregivers in India and South Africa
por: Dada, Shakila, et al.
Publicado: (2020)

Provider‐ and patient‐level costs associated with providing antiretroviral therapy during the postpartum phase to women living with HIV in South Africa: A cost comparison of three postpartum models of care
por: Cunnama, Lucy, et al.
Publicado: (2020)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa
por: Hanifa, Yasmeen, et al.
Publicado: (2017)

Costs of seasonal influenza vaccination in South Africa
por: Fraser, Heather, et al.
Publicado: (2022)

Tuberculosis prevention in children: a prospective community-based study in South Africa
por: Mandalakas, Anna M., et al.
Publicado: (2021)

Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005–2013
por: Joubert, Liezl, et al.
Publicado: (2018)

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis
por: Jayawardana, Sahan, et al.
Publicado: (2022)

Cost-effectiveness of routine adolescent vaccination with an M72/AS01(E)-like tuberculosis vaccine in South Africa and India
por: Harris, Rebecca C., et al.
Publicado: (2022)

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study
por: Verguet, Stéphane, et al.
Publicado: (2017)

A retrospective review of colistin utilisation at a tertiary care academic hospital in South Africa
por: Majavie, Liezl, et al.
Publicado: (2021)

Public Health Impact and Cost-Effectiveness of Screening for Active Tuberculosis Disease or Infection Among Children in South Africa
por: Brough, Joseph, et al.
Publicado: (2023)

Cost-effectiveness analysis of different screening and diagnostic strategies for sexually transmitted infections and bacterial vaginosis in women attending primary health care facilities in Cape Town
por: Smith, Elise, et al.
Publicado: (2023)

Modelling the healthcare costs of skin cancer in South Africa
por: Gordon, Louisa G., et al.
Publicado: (2016)

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

Using Top‐down and Bottom‐up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale
por: Cunnama, Lucy, et al.
Publicado: (2016)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Using system dynamics modelling to estimate the costs of relaxing health system constraints: a case study of tuberculosis prevention and control interventions in South Africa
por: Bozzani, Fiammetta M, et al.
Publicado: (2021)

The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa
por: Conteh, Lesong, et al.
Publicado: (2010)

Cost and cost-effectiveness of a parenting programme to prevent violence against adolescents in South Africa
por: Redfern, Alice, et al.
Publicado: (2019)

Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
por: Gomez, G. B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jqhoo4i8nudqe285rctp3mbfoq